位置:首页 > 蛋白库 > TAOK2_XENLA
TAOK2_XENLA
ID   TAOK2_XENLA             Reviewed;        1025 AA.
AC   Q6GPK9;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 92.
DE   RecName: Full=Serine/threonine-protein kinase TAO2;
DE            EC=2.7.11.1;
DE   AltName: Full=Thousand and one amino acid protein 2;
GN   Name=taok2;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Oocyte;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in different
CC       processes such as apoptotic morphological changes, MAPK8/JNK and
CC       MAPK14/p38 MAPK signaling pathway. {ECO:0000250}.
CC   -!- FUNCTION: Activates the JNK MAP kinase pathway. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC073108; AAH73108.1; -; mRNA.
DR   RefSeq; NP_001085661.1; NM_001092192.1.
DR   AlphaFoldDB; Q6GPK9; -.
DR   SMR; Q6GPK9; -.
DR   BioGRID; 102250; 1.
DR   IntAct; Q6GPK9; 2.
DR   DNASU; 444087; -.
DR   GeneID; 444087; -.
DR   KEGG; xla:444087; -.
DR   CTD; 444087; -.
DR   Xenbase; XB-GENE-5714849; taok2.L.
DR   OrthoDB; 617606at2759; -.
DR   Proteomes; UP000186698; Chromosome 9_10L.
DR   Bgee; 444087; Expressed in brain and 19 other tissues.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB.
DR   GO; GO:0007095; P:mitotic G2 DNA damage checkpoint signaling; ISS:UniProtKB.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Coiled coil; Kinase; Magnesium; Nucleotide-binding;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..1025
FT                   /note="Serine/threonine-protein kinase TAO2"
FT                   /id="PRO_0000086736"
FT   DOMAIN          28..281
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          349..377
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          899..930
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          945..1025
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          457..650
FT                   /evidence="ECO:0000255"
FT   COILED          755..876
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        349..374
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        950..982
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1003..1025
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        151
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         34..42
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         57
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
SQ   SEQUENCE   1025 AA;  118120 MW;  E15640DC0E9E480D CRC64;
     MPSNARAGNL KDPEVAELFF KDDPEKLFAD LREIGHGSFG AVYFARDIRN NEVVAIKKMS
     YSGKQSNEKW QDIIKEVKFL QKLRHPNTIE YKGCYLREHT AWLVMEYCLG SASDLLEVHK
     KPLQEMEIAA ITHGALQGLA YLHNHNMIHR DVKAGNILLT EPGLVKLGDF GSASIMAPAN
     SFVGTPYWMA PEVILAMDEG QYDGKVDVWS LGITSIELAE RKPPLFNMNA MSALYHIAQN
     ESPVLQSNHW SEYFRNFVDS CLQKIPQDRP TSDMLLKHRF LQRERPQTVI MELIQRTKDA
     VRELDNLQYR KMKKILFQDT QNGPNTETTE EEEEAEQFLH CTGTITSMES SQSVPSMSIS
     ASSQSSSVNS LADASDDSGE MAMMQEGEHT VTSNSSVIHR LPAHDNIYDD PYQPEMEAQQ
     SSSAARRRAY CRNRDHFATI RTASLVTRQI QEHEQDSALR EQMSGYKRMR RQHQKQLMAL
     ENKLKSELDE HQQRLDKELE AHRSNFSAEN EKISKKHQAI FEKEAKGGMT EEKKFQQHIL
     GQQKKELTNL LESQKRQYKI RKEQLKEELQ ENQSTPKREK QEWLLRQKES MQHYQAEEEA
     NLLRRQRQYF ELQCRQYKRK MLLARHNLDQ DLLREELNKK QTQRDLECAM LLRQHECTQE
     LEFRHLQLLQ HTRSELIRMQ HQTELGNQLE YNKRREQELR QKHAAEVRQQ PKSLKSKELQ
     IKRQFQDTCK IQTRQYKALR NHLLETTPKS EHKSILKRLK DEQTRKLAIL AEQYDHSINE
     MLSTQALRLD ETQEAEYQEL RIQLQKELEL LNAYQSKIKI HTDAQHEREL KELEQRVSIR
     RALLEQRIEE EMLALQTERS ERIRSLLERQ AREIEAFDSE SMRLGFSNMA LTGIPAEAFN
     QGYQAPPPGW PSRPVPRSGS HWSHGVQNTG APQLWRQPTL LAPPSASWGL HPPGSSSSLS
     ALPSSSSSSS SSPSSSSGGR PGLLLLRNSP QPLRRGGSGG PSEAGLSRST SVTSQLSNGS
     HLSYS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025